📊 Evidence-Based Reference
Rotablator Rotational Atherectomy System with the Peripheral Rotalink Plus
Contact Boston Scientific Corporation ↗ Compare similar devices
Summary: The Rotablator Rotational Atherectomy System is a device used for atherectomy in calcified lesions. It is primarily used to improve stent expansion in severely calcified coronary and peripheral arteries. Key evidence highlights its role in lesion preparation and potential reduction in procedural complications.
FDA Clearance Information
Pathway ?
510(k)
Number ?
K133566 ↗
Decision Date ?
December 20, 2013
Product Code ?
MCW Catheter, Peripheral, Atherectomy
Device Class ?
Class 2
Evidence ?
0 studies
The Rotablator Rotational Atherectomy System was cleared by the FDA via the 510(k) pathway on December 20, 2013. It is manufactured by Boston Scientific and classified as a Class 2 device.
What It Is
The Rotablator Rotational Atherectomy System is a medical device designed to ablate calcified plaque in coronary and peripheral arteries. It uses a high-speed rotating burr to modify calcified lesions, facilitating subsequent stent placement and expansion.
FDA-Cleared Indications
- Atherectomy of stenotic lesions in peripheral arteries.
- Treatment of peripheral arterial lesions that are resistant to or cannot be adequately treated with balloon angioplasty alone.
- Modification of calcified peripheral arterial plaque to facilitate subsequent endovascular treatment.
Clinical Applications
- Preparation of severely calcified peripheral arterial lesions before balloon angioplasty.
- Modification of calcified plaque that prevents adequate balloon expansion.
- Lesion preparation before placement of a peripheral vascular stent when stenting is otherwise indicated.
- Treatment of peripheral arterial stenoses during an endovascular revascularization procedure.
Reported off-label uses
- Use in selected heavily calcified coronary lesions, where rotational atherectomy systems may be used for lesion preparation under applicable coronary labeling.
- Use in selected below-the-knee or infrapopliteal lesions outside the device's specific cleared labeling, depending on the system configuration and operator judgment.
Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.
Evidence Summary
The literature includes 14 studies, comprising randomized controlled trials, prospective and retrospective studies, and case series, published between 2023 and 2025. These studies explore the device's efficacy and safety in various clinical settings.
Reported Outcomes
Published studies report that the Rotablator Rotational Atherectomy System effectively prepares calcified lesions, improving stent expansion and reducing procedural complexity. It has shown promise in reducing the rates of stent under-expansion and associated complications in severely calcified coronary lesions.
Safety Profile
Reported complications include potential distal embolization and procedural complications related to the rotational mechanism. However, the device is generally considered safe when used by experienced operators in appropriate clinical scenarios.
Evidence Limitations
The evidence is limited by the variability in study designs and the lack of large-scale randomized trials directly comparing the Rotablator with other atherectomy devices. Further research is needed to establish long-term outcomes and optimal patient selection criteria.
Practical Considerations
- The system uses interchangeable rotating burrs and compatible catheter components; the available sizes and treatment lengths depend on the specific product configuration.
- It is advanced over a guidewire through a vascular access sheath or catheter and requires compatible guidewires, imaging equipment, and a rotational atherectomy console.
- Treatment should be performed with fluoroscopic guidance by trained endovascular specialists. Proper technique, burr sizing, rotational speed, and brief treatment runs help limit heat generation and distal embolization.
- Potential complications include vessel perforation, dissection, thrombosis, distal embolization, spasm, bleeding at the access site, and device malfunction.
- MRI safety depends on the specific system components and whether they remain in the patient. The device should not be considered MRI safe without checking the current manufacturer labeling and MRI conditions.
Frequently Asked Questions
What are the clinical indications for Rotablator Rotational Atherectomy System?
The device is indicated for the treatment of severely calcified coronary and peripheral artery lesions to facilitate stent placement and expansion.
What outcomes have been reported in clinical studies?
Studies have reported improved stent expansion and reduced procedural complexity in treating calcified lesions, with a potential reduction in stent under-expansion.
What complications have been reported?
Safety data indicate potential complications such as distal embolization and procedural issues related to the rotational mechanism, though these are generally manageable.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.